0.1701
900 319 0030
x

Weeding out Unregulated Drugs

iasparliament Logo
March 23, 2018

What is the issue?

  • Various new drugs and combination medicines that are currently available in the market haven’t got the necessary regulatory approvals.
  • Drug Controller General of India (DGCI) has State regulators to review and recall such medicines immediately.

What did the recent directives come up?

  • Recently, raids were conducted by the Central Drugs Standards Control Organisation (CDSCO) on some manufacturing plants in Uttarakhand.
  • It emerged that 70 of the 118 products that were manufactured were without the DCGI approval, though they had been licensed by the State authorities.
  • This was in contravention to law as new drug are not supposed to be manufactured without the approval of the central drug regulator. 
  • State authorities have been asked to not give manufacturing approvals for new drugs and combination medicines without DGCI consent.

What are combination medicines and what is their status?

  • Combination medicines are ones that combine 2 or more dosages in fixed proportions in order to address illness that often accompany each other.
  • Currently, even if Fixed Dose Combinations (FDC) of already approved drugs is to be released, it needs prior DCGI approval. 
  • Notably, the union government had also banned of 344 FDC Drugs in 2016 as they found them to be unsafe despite individual doses being safe.
  • While the Supreme Court upheld the same in subsequent litigations, compliance wasn’t strictly forced on the pharma manufacturers by the states.
  • Significantly, of 118 different FDC formulations sold in India between 2007 and 2012, it was found that only 43 were approved by the central regulators.
  • It is to be noted that, the 118 FDC formulations were sold in over 3300 branded products made by about 500 different pharmaceutical manufacturers.

What is the way ahead?

  • There are big risks for the society at large as unregulated dosages could affect patient health as well as promote drug resistance among microbes.
  • Multinational companies were found to be manufacturing many unapproved formulations, despite pledging to tackle rising antimicrobial resistance.
  • Drug resistance emerges as a result of erratic consumption of drugs that aid microbes to become immune to drugs and makes tackling illness tough.
  • Hence, state regulatory authorities should ensure that they don’t approve any FDC drug without DCGI clearance and also ensure manufacturer compliance.

 

Quick Facts

Central Drugs Standard Control Organization (CDSCO):

  • CDSCO is the national regulatory body for pharmaceuticals and medical devices in India.
  • It is divided into zonal offices which do pre-licensing and post-licensing inspections, post-market surveillance, and recalls when needed.
  • Drug Controller General of India (DCGI) is an organ of the CDSCO which is responsible for approving and licensing of drugs and medical devices.
  • The DCGI is advised by the Drug Technical Advisory Board (DTAB) and the Drug Consultative Committee (DCC).

 

Source: Business Line

 

Login or Register to Post Comments
There are no reviews yet. Be the first one to review.

ARCHIVES

MONTH/YEARWISE ARCHIVES

Free UPSC Interview Guidance Programme